[4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone
C26H26BrN5O2 — CID 129225991
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone
[4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone (PubChem CID 129225991) has the molecular formula C26H26BrN5O2 and a molecular weight of 520.43 g/mol. Its IUPAC name is [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone.
Molecular Properties
| Compound Name | [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone |
|---|---|
| PubChem CID | 129225991 |
| Molecular Formula | C26H26BrN5O2 |
| Molecular Weight | 520.43 g/mol |
| Exact Mass | 519.13 |
| IUPAC Name | [4-[[2-(4-bromophenyl)imidazo[1,2-a]pyridin-3-yl]methyl]piperazin-1-yl]-(6-methoxy-3-methyl-2-pyridinyl)methanone |
| SMILES | COc1ccc(C)c(C(=O)N2CCN(Cc3c(-c4ccc(Br)cc4)nc4ccccn34)CC2)n1 |
| InChI | InChI=1S/C26H26BrN5O2/c1-18-6-11-23(34-2)29-24(18)26(33)31-15-13-30(14-16-31)17-21-25(19-7-9-20(27)10-8-19)28-22-5-3-4-12-32(21)22/h3-12H,13-17H2,1-2H3 |
| InChIKey | VTOOBSYEGXFOPO-UHFFFAOYSA-N |
| XLogP | 4.43 |
| TPSA | 62.97 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.43 |
| LogP ≤ 5 | 4.43 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129225991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.